Pharma BD Deal Intelligence
GenturaDx / LUMINEX CORP
2012 · Acquisition/Merger · $50M · Complete
Announcement Sentiment
75
Strongly positive
Outcome Score
48
Mixed — partial payoff, real shortfalls.
Luminex Corporation acquired GenturaDx for $50 million in cash to expand its molecular diagnostics platform, adding GenturaDx's sample-to-answer real-time PCR and MultiCode-RTx chemistry.
Key facts
Announced Sep 18, 2012 Closed Sep 18, 2012 Deal value $50M Deal type Acquisition/Merger Therapeutic area Infectious Disease, Respiratory
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
The Pharma Closeout — Deal Intelligence Database.
Announcement Sentiment and Outcome Score from sourced facts.Home ·
Deals ·
Methodology ·
About